A harmonized resource of integrated prostate cancer clinical, -omic, and signature features

Sci Data. 2023 Jul 5;10(1):430. doi: 10.1038/s41597-023-02335-4.

Abstract

Genomic and transcriptomic data have been generated across a wide range of prostate cancer (PCa) study cohorts. These data can be used to better characterize the molecular features associated with clinical outcomes and to test hypotheses across multiple, independent patient cohorts. In addition, derived features, such as estimates of cell composition, risk scores, and androgen receptor (AR) scores, can be used to develop novel hypotheses leveraging existing multi-omic datasets. The full potential of such data is yet to be realized as independent datasets exist in different repositories, have been processed using different pipelines, and derived and clinical features are often not provided or not standardized. Here, we present the curatedPCaData R package, a harmonized data resource representing >2900 primary tumor, >200 normal tissue, and >500 metastatic PCa samples across 19 datasets processed using standardized pipelines with updated gene annotations. We show that meta-analysis across harmonized studies has great potential for robust and clinically meaningful insights. curatedPCaData is an open and accessible community resource with code made available for reproducibility.

MeSH terms

  • Datasets as Topic
  • Gene Expression Profiling
  • Genomics
  • Humans
  • Male
  • Meta-Analysis as Topic
  • Prostatic Neoplasms* / genetics
  • Prostatic Neoplasms* / pathology
  • Reproducibility of Results
  • Transcriptome